GB2137193A - Chlorosulphonic Acid Esters - Google Patents

Chlorosulphonic Acid Esters Download PDF

Info

Publication number
GB2137193A
GB2137193A GB08308615A GB8308615A GB2137193A GB 2137193 A GB2137193 A GB 2137193A GB 08308615 A GB08308615 A GB 08308615A GB 8308615 A GB8308615 A GB 8308615A GB 2137193 A GB2137193 A GB 2137193A
Authority
GB
United Kingdom
Prior art keywords
formula
chlorosulfate
compound
reaction
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08308615A
Other versions
GB2137193B (en
GB8308615D0 (en
Inventor
Mogens Kran-Nielsen
Erik Torngard Hansen
Ernst Torndal Binderup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Priority to GB08308615A priority Critical patent/GB2137193B/en
Publication of GB8308615D0 publication Critical patent/GB8308615D0/en
Priority to SE8401280A priority patent/SE8401280L/en
Priority to IT8467298A priority patent/IT8467298A0/en
Priority to DE19843411242 priority patent/DE3411242A1/en
Priority to JP59062079A priority patent/JPS59184156A/en
Priority to FR8404872A priority patent/FR2543547A1/en
Publication of GB2137193A publication Critical patent/GB2137193A/en
Application granted granted Critical
Publication of GB2137193B publication Critical patent/GB2137193B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00Esters of sulfuric acids
    • C07C305/26Halogenosulfates, i.e. monoesters of halogenosulfuric acids

Abstract

Novel compounds of the formula <IMAGE> in which X is halogen or <IMAGE> and R1 and R2 are hydrogen or alkyl are useful in the preparation of alpha -haloalkyl esters or alkylene di-esters of carboxylic acids, e.g. 1,1-dioxopenicillanic acid esters.

Description

SPECIFICATION Chemical Compounds The present invention relates to new important intermediates, e.g. for use in the preparation of ahaloalkyl esters or alkylene di-esters of carboxylic acids. The invention also relates to methods for the preparation of these new intermediates, such methods also being useful in the preparation of compounds of similar structure.
The new intermediates are represented by formula I
in which formula X is halogen, e.g. chlorine or bromine, or another good leaving group, e.g.
and R1 and R2 are hydrogen or lower alkyl.
The compound of formula I in which R, and R2 are both hydrogen and X stands for chlorine is known from Ber. 60, 2288 (1927).
The compounds of formula I are very effective reagents for introducing the
group, e.g. when preparing a-haloalkyl esters of formula II
in which formula R1 and R2 have the above meanings, X is halogen, and R indicates an organic residue, by reacting a salt of a carboxylic acid R--COOH with a compound of formula I (X=halogen), thus obtaining the compound of formula II in better yields and of higher purity than when using the usual method of reacting a dihaloalkane with a salt of a carboxylic acid.
Depending on the reactivity of the leaving group X as compared with the reactivity of the chlorosulphonyloxy group as leaving group, it is possible to produce a compound of formula Ila
in which R, R1 and R2 have the above meanings, and X' stands for X or for
i.e. if X has less or the same ractivity as
The compounds of formula I are esters of chlorosulphonic acid. As a-halo-substituted alcohols do not exist, it is not possible to prepare these compounds by the standard method of reacting sulfuryl chloride with such alcohol.
According to the present invention, the compounds of formula I may be prepared by reacting chlorosulfonic acid with a compound of formula Ill
in which formula R1, R2 and X have the above meanings, and Y stands for a better leaving group than X. In case Y has the same reactivity as X, the reaction will give bis(chlorosulphate)alkane. The reaction is performed with or without a solvent present depending upon the reactants in questions, and at a temperature between --200C and 1000C.
In a second method of the invention, the compounds of formula I in which X stands for halogen, in particular chlorine, may be prepared by a photochemical halogenation of alkyl chlorosulfates of the formula V
in which R1 and R2 are as above, if desired, dissolved in a suitable, to the reaction inert organic solvent, such as carbon tetrachloride, into which the desired halogen is introduced with simultaneous irradiation of the solution. When the reaction has taken place, the product is isolated e.g. by distillation.
If in formula I R1=R2=H and
this compound, bis(chlorosulphate)methane, may be prepared by a reaction between chloromethyl chlorosulfate and sulphur trioxide. The compound is obtained from the reaction mixture by distillation at low pressure.
The present invention will be further illustrated by the following examples which shall not be considered limiting the scope of the invention.
EXAMPE 1 Chloromethyl Chlorosulfate Chlorosulfonic acid (200 ml, 349 g, 3 mol) and bromochloromethane (100 ml, 194 g, 1.5 mol) were mixed and refluxed for 3 hours. A large amount of bromine was generated. The mixture was cooled and poured into ice, and methylene chloride (100 ml) was added. The organic phase was washed with water (100 ml), dried with magnesium sulfate and solvent was removed in vacuo along with bromine. The residue (93.7 g) was distilled in vacuo, and chloromethyl chlorosulfate was collected at 45-500C/9-1 0 mm Hg.
EXAMPLE 2 Chloromethyl Chlorosulfate A solution of chlorosulfonic acid (58.3 g, 33.3 ml, 0.5 mol) was added during 1/2 hour from a dropping funnel to an ice-cold solution of chloroiodomethane (44.1 g, 18.3 ml, 0.25 mol) in methylene chloride (100 ml). After stirring for another hour with ice cooling, the mixture was poured into ice. The organic phase was washed with water, decolourised with sodium thiosulfate and dried with magnesium sulfate. The almost colourless organic phase was concentrated in vacuo (22.4 g). Distillation in vacuo gave chloromethyl chlorosulfate at 42--450C/9 mmHg.
EXAMPLE 3 Chloromethyl Chlorosulfate A flask containing methyl chlorosulfate (10 ml) was placed in a water bath at room temperature.
Chlorine was bubbled through the liquid which was irradiated with ultraviolet light from a high pressure lamp. After 3 hours, an NMR-spectrum indicated a 70% conversion to chloromethyl chlorosulfate. The mixture was cooled in ice and methanol (4.6 ml) was added in order to destroy unreacted methyl chlorosulfate. Distillation in vacuo gave pure chloromethyl chlorosulfate, b.p.
550C/20 mmHg.
EXAMPLE 4 a-Chloroethyl Chlorosulfate A reaction flask containing ethyl chiorosulfate (15 ml) was placed in water bath at room temperature and irradiated with UV-light from a high pressure lamp while chlorine was bubbled through the liquid. The reaction was followed by NMR-spectroscopy and the chlorination was stopped when all the starting material was used up. The system was flushed with nitrogen and the product (a mixture of chlorination products) was distilled in vacuo through a Vigreux column. The fraction with boiling point 49-51 OC/10 mmHg was a-chloroethyl chlorosulfate.
The IR-spectrum (CH2CI2) showed strong bands at 1415, 1192, 900 and 600 cm-'. The NMRspectrum (CDCI3) showed peaks at b=1.97 (d, J=5.9 Hz, 3H), and 6.47 (q, J=5.9 Hz, 1 H) ppm.
EXAMPLE 5 a-Chloroethyl Chlorosulfate Chlorosulfonic acid (10 ml) was slowly added to an ice-cold stirred solution of 1-chloro-1 iodoethane (9.3 ml) in methylene chloride (50 ml). After stirring for another hour with icecooling, the dark red mixture was poured on ice.
The aqueous phase was extracted with methylene chloride and the combined organic phases were washed with aqueous sodium bicarbonate and aqueous sodium thiosulfate. The almost colourless organic phase was dried and concentrated in vacuo. Distillation in vacuo gave a-chloroethyl chlorosulfate identical with the product obtained in Example 4).
EXAMPLE 6 Bromomethyl Chlorosulfate Chlorosulfonic acid (52.4 g, 30 ml, 0.45 mol) was in four equal amounts with 1/2 hour intervals added to an ice-cold stirred solution of bromoiodo methane (22.1 g, 7.55 ml, 0.1 mol) in tetrachloro methane (100 ml). After stirring for another 1/2 hour the mixture was poured on ice and filtrated.
The organic phase was washed with water, decolourised with sodium thiosulfate and dried with magnesium sulfate. Distillation in vacuo gave bromomethyl chlorosulfate at 62-660C/12 mmHg.
NMR'H: 6.00 (CDCl3).
Calculated for CH2BrCIO3S: C: 5.73, H: 0.96, S: 15.31.
Found: C: 5.88, H: 0.96, S: 15.63.
EXAMPLE 7 Bis(chlorosulfate)methane Chloromethyl chlorosulfate (62.5 g, 40 ml, 395 mmol) and sulfurtrioxide (38.3 g, 478 mmol) were mixed at room temperature. The mixture was after 20 days poured into ice, and methylene chloride (100 ml) was added. The organic phase was washed with water (100 ml), dried with magnesium sulfate and solvent was removed in vacuo. The residue was distilled in vacuo 10-11 mmHg, whereby chloromethyl chlorosulfate (starting material) was obtained at 41--45 OC and bis(chlorosulfate)methane at 1 02--1 05 0 C/8--1 0 mmHg.
NMR'H: 6.15 (CCI4).
Calculated for CH2(OSO2CI)2: C: 4.90, H: 0.82, S: 26.17, Cl: 28.94.
Found: C: 5.12, H: 0.86, S: 25.79, CI: 28.79.
EXAMPLE 8 Bis(chlorosulfate)methane Chlorosulfonic acid (74.6 ml) was added slowly to a stirred ice-cold solution of methylene iodide, (15 ml) in methylene chloride (100 ml). After stirring for a further 30 minutes, the reaction mixture was poured on ice. The organic phase was separated, washed with aqueous sodium bicarbonate and sodium thiosulfate, and dried over magnesium sulfate. The solvent was removed by distillation at atmospheric pressure, and the residue was distilled in vacuo.
Bis(chlorosulfate)methane distilled at 108 1 100C/10 mmHg.
EXAMPLE 9 Bis(1,1 -dioxopenicillanate)methane Water (150 ml) methylene chloride (200 ml), tetrabutylammonium-hydrogen sulfate (1.0 g), sodium hydrogen-carbonate (13.4 g, 160 mmol) and penicillanic acid-1,1-dioxide (11.65 g, 50 mmol) was charged and cooled to 20C.
Bis(chlorosulfate)methane (5 g,21 mmol) in methylene chloride (30 ml) was added during 1/2 hour. The mixture was allowed to react 1 hour at 20C and 1 hour at room temperature. The reaction mixture was separated, and the water phase was extracted with methylene chloride '(100 ml). The combined methylene chloride phases were dried with MgSO4 and filtered.
Isopropanol was added, and methylene chloride was evaporated in vacuo while bis(1 ,1- dioxopenicillanate)methane crystallizes. Filtration and drying gave a pure product, the NMR of which was identical with that of an authentic sampie, confer U.S. patent No. 4,309,347.
EXAMPLE 10 a-Chloroethyl 1,1 -Dioxopenicillanate The temperature of a mixture of sodium 1,1 dioxopenicillanate (8.85 g), water (35 ml), methylene chloride (35 ml), sodium bicarbonate (11.7 g) and tetrabutylammonium hydrogen sulfate (1.2 g) was adjusted to 20-220C.
a-Chloroethyl chlorosulfate (7.17 g) was added during 1 5 minutes to the stirred rriixture. After stirring for a further 30 minutes sodium iodide (5 g) was added followed by sodium thiosulfate to decolourize the mixture. The organic phase was separated, dried and concentrated in vacuo. Ethyl acetate was added, and the remaining methylene chloride was removed in vacuo. The product (a mixture of the two diastereomeric forms) crystallized from ethyl acetate.
The NMR-spectrum (CDCl3) showed both diastereomeric forms (in the foilowing called A and B): Form A showed peaks at os=1.45 .45(s, 3H), 1.65 (s, 3H), 1.87 (d, J=5.5 Hz, 3H), 3.49 (d, J=4 Hz, 2H), 4.40 (s, 1 H)., 4.67 (t, J=4 Hz, 1 H) and 6.59 (q, J=5.5, 1 H) ppm.
Form B showed peaks at =1 8=1.48 3H), 65 (s, 3H-), 1.87 (d, J=5.5 Hz, 3H), 3.49 (d, J=4 Hz, 2H), 4.42 (s, 1H), 4.67 (t, J=4 Hz, 1 H), and 6.63 (q, J=5.5 Hz, 1 H) ppm.
EXAMPLE 11 Bromomethyl 1,1 -Dioxopenicillante This compound was prepared as described for a-chloroethyl 1,1-dioxopenicillanate by substituting bromomethyl chlorosulfate for cr-chloroethyl chlorosulfate.
The NMR-spectrum (CDCl3) showed peaks at S=1.50 (s, 3H), 1.63 (s, 3H), 3.50 (d, J=4 Hz, 2H), 4.45 (s, 1 H), 4.67 (t, J=4 Hz, 1 H), 5.76 (d, J=5 Hz,1 H), and 6.08 (d, J=5 Hz, 1 H) ppm.

Claims (9)

1. New intermediates of the formula I
in which formula X is halogen, e.g. chlorine or bromine, or another good leaving group, e.g.
and R1 and R2 are hydrogen or lower alkyl, with the proviso that when X is chlorine, at least one of R1 and R2 is lower alkyl.
2. Intermediate according to claim 1 which is bis(chlorosulfate)methane.
3. Intermediate according to claim 1 which is a-chloroethylchlorosulfate.
4. Intermediate according to claim 1 which is bromomethyl chlorosulfate.
5. Method for producing a compound of formula I
in which formula X is halogen, e.g. chlorine or bromine, or another good leaving group, e.g.
and R1 and R2 are hydrogen or lower alkyl, wherein chlorosulfonic acid is reacted with a compound of formula III
in which formula R1, R2 and X have the above meanings, and Y stands for a better leaving group than X, the reaction being performed with or without a solvent present depending upon the reactants in question, and at a temperature between -200C and 100 C.
6. Method for producing a compound of formula I of claim 5, in which X stands for halogen, in particular chlorine, wherein an alkyl chlorosulfate of the formula V
in which R1 and R2 are as above, is halogenated photochemically, if desired with the alkyl chlorosulfate dissolved in a suitable, to the reaction inert organic solvent, such as carbon tetrachloride, into which the desired halogen is introduced with simultaneous irradiation of the solution, whereafter, when the reaction has taken place, the product is isolated e.g. by distillation.
7. Method for producing a compound of formula I of claim 5, in which.R1=R2=H and
wherein chloromethyl chlorosulfate is reacted with sulphur trioxide, isolating the reaction product from the reaction mixture by distillation at low pressure.
8. A new intermediate of the formula I defined in claim 1 substantially as hereinbefore described in any one of the foregoing examples.
9. Method for producing a compound of formula I defined in claim 1 substantially as hereinbefore described in any one of the foregoing examples.
GB08308615A 1983-03-29 1983-03-29 Chlorosulphonic acid esters Expired GB2137193B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB08308615A GB2137193B (en) 1983-03-29 1983-03-29 Chlorosulphonic acid esters
SE8401280A SE8401280L (en) 1983-03-29 1984-03-07 INTERMEDIATES AND THE PROCEDURE FOR PRODUCING THEREOF
IT8467298A IT8467298A0 (en) 1983-03-29 1984-03-27 INTERMEDIATE COMPOUNDS PARTICULARLY FOR THE PREPARATION OF ALPHA-HALOALKYLESTERS OR ALKYLENIC DIESTERS OF CARBOXYLIC ACIDS AND PROCEDURE FOR THEIR PREPARATION
DE19843411242 DE3411242A1 (en) 1983-03-29 1984-03-27 ALKYL CHLORINE SULFATE INTERMEDIATE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
JP59062079A JPS59184156A (en) 1983-03-29 1984-03-28 Chlorosulfonic acid ester and manufacture
FR8404872A FR2543547A1 (en) 1983-03-29 1984-03-28 NOVEL MONO AND BIS-CHLOROSULFONATES, USEFUL AS INTERMEDIATES, AND PROCESSES FOR THEIR PREPARATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08308615A GB2137193B (en) 1983-03-29 1983-03-29 Chlorosulphonic acid esters

Publications (3)

Publication Number Publication Date
GB8308615D0 GB8308615D0 (en) 1983-05-05
GB2137193A true GB2137193A (en) 1984-10-03
GB2137193B GB2137193B (en) 1986-05-08

Family

ID=10540408

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08308615A Expired GB2137193B (en) 1983-03-29 1983-03-29 Chlorosulphonic acid esters

Country Status (6)

Country Link
JP (1) JPS59184156A (en)
DE (1) DE3411242A1 (en)
FR (1) FR2543547A1 (en)
GB (1) GB2137193B (en)
IT (1) IT8467298A0 (en)
SE (1) SE8401280L (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704456A (en) * 1985-11-22 1987-11-03 Pfizer Inc. Process for sultamicillin intermediate
US4942229A (en) * 1987-11-25 1990-07-17 Yoshitomi Pharmaceutical Industries, Ltd. Process for the production of penicillanic acid compounds
CN107986995A (en) * 2017-12-08 2018-05-04 和夏化学(太仓)有限公司 A kind of preparation method of methyl dichloro sulphonic acid ester

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111548258A (en) * 2019-02-12 2020-08-18 北京旭阳科技有限公司 Use of sulfonyl type compounds as chlorination reagents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1355204A (en) * 1970-08-31 1974-06-05 Stauffer Chemical Co Antidote compositions and method of use with herbicides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238240A (en) * 1963-09-20 1966-03-01 Pennsalt Chemicals Corp Perhaloalkyl chlorosulfates and fluorosulfates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1355204A (en) * 1970-08-31 1974-06-05 Stauffer Chemical Co Antidote compositions and method of use with herbicides

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704456A (en) * 1985-11-22 1987-11-03 Pfizer Inc. Process for sultamicillin intermediate
US4942229A (en) * 1987-11-25 1990-07-17 Yoshitomi Pharmaceutical Industries, Ltd. Process for the production of penicillanic acid compounds
EP0382863A1 (en) * 1987-11-25 1990-08-22 Yoshitomi Pharmaceutical Industries, Ltd. Process for the production of penicillanic acid compounds
CN107986995A (en) * 2017-12-08 2018-05-04 和夏化学(太仓)有限公司 A kind of preparation method of methyl dichloro sulphonic acid ester

Also Published As

Publication number Publication date
FR2543547A1 (en) 1984-10-05
SE8401280D0 (en) 1984-03-07
SE8401280L (en) 1984-09-30
GB2137193B (en) 1986-05-08
GB8308615D0 (en) 1983-05-05
DE3411242A1 (en) 1985-01-10
IT8467298A0 (en) 1984-03-27
JPS59184156A (en) 1984-10-19

Similar Documents

Publication Publication Date Title
US4358412A (en) Preparation of vinyl ethers
KR840001918B1 (en) Process for the preparation of -chlorinated chloroformates
EP1288198B1 (en) Process for the production of sulfonic esters
US5130477A (en) Oligohexafluoropropylene oxide derivatives and method of making
EP0645365B1 (en) Process for producing 2-fluoroisobutyric acid or ester thereof
GB2137193A (en) Chlorosulphonic Acid Esters
EP0147472B1 (en) 4-chloro-4-methyl-5-methylene-1,3-dioxolan-2-one
EP0372635A2 (en) Method of preparing dialkyl and diallyl dicarbonates
JPH06509553A (en) Method for producing phenyl ester of substituted acid
US5057633A (en) Synthesis of perfluoroalkyl bromides
KR940000060B1 (en) Process of synthesis of acylcyanamides
US4107181A (en) Useful prostaglandin intermediates
CA2523419C (en) Process for preparation of (+)-p-mentha-2,8-diene-1-ol
JP3091022B2 (en) Method for producing glutaric acid derivative
US5194651A (en) Tosylation of alcohols
US4052434A (en) Prostaglandin intermediates
US4058567A (en) Cyclopentene sulfoxides
JPH08803B2 (en) Method for producing fluorine-containing phthalonitrile derivative
JP3549567B2 (en) Method for producing optically active scandium complex and optically active cyclic compound
JPS5944315B2 (en) Method for producing 2-pentynyl ether
SU1105495A1 (en) Method of obtaining dichloranhydride-2-alkoxyvinylphosphonic acids
JP3296919B2 (en) Method for producing optically active cyclic compound
GB1588870A (en) Peroxides and hydroperoxides
JPH0940596A (en) Production of 2,3,6,7,10,11-hexaalkoxytriphenylenes
JPH11279099A (en) Production of ether compound

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee